These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2474905)

  • 1. [Characteristics of the immune response in mice immunized with the inactivated Lassa virus].
    Ignat'ev GM; Golubev VP; Godneva AT; Petkevich AS; Torop AV
    Vopr Virusol; 1989; 34(2):213-6. PubMed ID: 2474905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A trial to produce an inactivated Lassa fever vaccine].
    Krasnianskiĭ VP; Potryvaeva NV; Borisevich IV; Gradoboev VN; Pashanina TP; Pshenichnov VA
    Vopr Virusol; 1993; 38(6):276-9. PubMed ID: 8303891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunization of rabbits with Lassa virus].
    Orlova SV; Godneva AT; Ignat'ev GM; Bystrova SI
    Vopr Virusol; 1990; 35(1):59-61. PubMed ID: 2363276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenic and protective characteristics of recombinant Lassa virus NP protein].
    Ignat'ev GM
    Vopr Virusol; 2002; 47(2):28-31. PubMed ID: 12046464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The indirect hemagglutination reaction for the detection of the Lassa virus].
    Vladyko AS; Kramarenko LP; Cherednichenko IA; Surikova LE
    Vopr Virusol; 1988; 33(4):498-502. PubMed ID: 3195147
    [No Abstract]   [Full Text] [Related]  

  • 6. Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development.
    Jahrling PB; Peters CJ
    Med Microbiol Immunol; 1986; 175(2-3):165-7. PubMed ID: 3724664
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever.
    Clegg JC; Lloyd G
    Lancet; 1987 Jul; 2(8552):186-8. PubMed ID: 2885642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dynamics of the formation of IgG subclasses in Balb/c and CBA mice infected with the LCM, Lassa and Mopeia viruses and their role in diagnosis].
    Zaĭtseva VN; Bystrova SI; Shkolina TV; Vladyko AS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):47-51. PubMed ID: 9221657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An evaluation of the possibility of obtaining an inactivated vaccine against Lassa fever].
    Krasnianskiĭ VP; Potryvaeva NV; Borisevich IV; Gradoboev VN; Pashanina TP; Pshenichnov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):74-5. PubMed ID: 7879553
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation between two African arenaviruses (Lassa and Mozambique) by plaque assay.
    Tomori O; Johnson K
    Acta Virol; 1987 Mar; 31(2):146-51. PubMed ID: 2886023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):49-54. PubMed ID: 7049096
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibition of the accumulation of the Lassa virus in Vero cells by immune gamma globulin and complement].
    Vladyko AS; Rogacheva TA; Orlova SV; Votiakov VI
    Vopr Virusol; 1984; 29(4):473-6. PubMed ID: 6208692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunity indices of animals immunized with the inactivated Marburg virus after infection with homologous virus].
    Ignat'ev GM; Strel'tsova MA; Agafonov AP; Zhukova NA; Kashentseva EA; Vorob'eva MS
    Vopr Virusol; 1994; 39(1):13-7. PubMed ID: 8160440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys.
    McCormick JB; Mitchell SW; Kiley MP; Ruo S; Fisher-Hoch SP
    J Med Virol; 1992 May; 37(1):1-7. PubMed ID: 1619397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of a plaque assay for Lassa virus.
    Tomori O; Johnson KM; Kiley MP; Elliott LH
    J Med Virol; 1987 May; 22(1):77-89. PubMed ID: 3585290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lassa fever virus in Senegal.
    Saluzzo JF; Adam F; McCormick JB; Digoutte JP
    J Infect Dis; 1988 Mar; 157(3):605. PubMed ID: 3343533
    [No Abstract]   [Full Text] [Related]  

  • 17. [The immunity indices of BALB/c mice immunized with an inactivated antigen of the Machupo virus].
    Ignat'ev GM; Tverdokhlebov AV; Kaliberov SA; Patrusheva IV; Kashentseva EA; Vorob'eva MS
    Vopr Virusol; 1993; 38(5):227-30. PubMed ID: 8284923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
    Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
    Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic.
    Georges AJ; Gonzalez JP; Abdul-Wahid S; Saluzzo JF; Meunier DM; McCormick JB
    Trans R Soc Trop Med Hyg; 1985; 79(1):78-9. PubMed ID: 2986324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of antigen and antibody accumulation in adult mice, infected with Lassa virus].
    Vladyko AS; Surikova LE; Kramarenko LP; Bystrova SI; Torop AV
    Vopr Virusol; 1989; 34(1):100-3. PubMed ID: 2658319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.